Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Breastfeeding and Disease-Modifying Therapy for Multiple Sclerosis.
Multiple Sclerosis in the Levant: A Regional Consensus Statement.
Does robot-assisted gait training ameliorate gait abnormalities in multiple sclerosis? A pilot randomized-control trial.
Brain atrophy as a non-response predictor to interferon-beta in relapsing-remitting multiple sclerosis.
[The Effect of the Disease Duration on the Changes of the Visual Evoked Potentials and Contrast Sensitivity in Multiple Sclerosis].
Modulation of Hyperosmotic and Immune-Induced Disruption of the Blood-Brain Barrier by the Nitric Oxide System.
Glatiramer acetate: a review of its use in patients with relapsing-remitting multiple sclerosis and in delaying the onset of clinically definite multiple sclerosis.
Microparticles: A New Perspective in Central Nervous System Disorders.
Application of human induced pluripotent stem cells for modeling and treating neurodegenerative diseases.
Clinically silent PML and prolonged immune reconstitution inflammatory syndrome in a patient with multiple sclerosis treated with natalizumab.
Employment and Community Living Issues for People with Multiple Sclerosis.
Synaptic vesicle release regulates myelin sheath number of individual oligodendrocytes in vivo.
HDAC1/2-Dependent P0 Expression Maintains Paranodal and Nodal Integrity Independently of Myelin Stability through Interactions with Neurofascins.
Induction Therapy for Patients with Multiple Sclerosis: Why? When? How?
Treatment of optic neuritis with erythropoietin (TONE): a randomised, double-blind, placebo-controlled trial-study protocol.
Predicting Breakdown of the Blood-Brain Barrier in Multiple Sclerosis without Contrast Agents.
The role of adenosine and adenosine receptors in the immunopathogenesis of multiple sclerosis.
Fatigue in multiple sclerosis: The contribution of occult white matter damage.
Meningeal Tertiary Lymphoid Tissues and Multiple Sclerosis: A Gathering Place for Diverse Types of Immune Cells during CNS Autoimmunity.
Optic coherence tomography findings in relapsing-remitting multiple sclerosis patients of the northwest of Iran.
Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.
Increasing the Contrast of the Brain MR FLAIR Images Using Fuzzy Membership Functions and Structural Similarity Indices in Order to Segment MS Lesions.
Brainstem and limbic encephalitis with paraneoplastic neuromyelitis optica.
Dock3 protects myelin in the cuprizone model for demyelination.
Increased thyroid autoimmunity among women with multiple sclerosis in the postpartum setting.
Pages
« first
‹ previous
…
423
424
425
426
427
428
429
430
431
…
next ›
last »